Monoclonal Anti-Human IgG Fc Antibody, Mouse IgG1 (6F11C8)

Customer Reviews
Cat. No. / Size
Price
Availability
Qty
IGG-S307-100ug
$360.00
In Stock - Delivery in 2-3 business days
IGG-S307-1mg
$2380.00
In Stock - Delivery in 2-3 business days

Product Details

  • Source

    Chimeric Monoclonal Anti-Human IgG Fc Antibody, Mouse IgG1 (6F11C8) is recombinantly expressed in CHO. It consists of mouse variable regions genetically fused to mouse IgG1 constant domains.

  • Antibody Type

    Recombinant Monoclonal

  • Clone

    6F11C8

  • Isotype

    Mouse IgG1, Kappa

  • Host Species

    Mouse

  • Reactivity

    Human IgG Fc, including IgG1–IgG4 isotypes and Fc-engineered variants (e.g. N297A, LALA, YTE, LS, S239D/I332E)

  • Immunogen

    Recombinant Human Fc derived from CHO cells

  • Specificity

    Specifically binds to the Fc region of human IgG without recognizing Fab fragments or mouse IgG isotypes.

  • Application

    Application
    Recommended Use / Performance
    ELISA
    0.2-2 μg/mL
  • Cross Verification

    Positive: Cross-reactive by ELISA with human IgG subclasses (IgG1, IgG2, IgG3, IgG4) and a panel of Fc-engineered variants including N297A, LALA, YTE, LS, S239D/I332E. Weak cross-reactivity by ELISA with cynomolgus IgG.
    Negative: No detectable cross-reactivity by ELISA with mouse IgG subclasses (IgG1, IgG2a, IgG2b).

  • Purification

    Protein A purified.

  • Aggregation

    Less than 10%, as determined by SEC-MALS.

  • Concentration

    Please refer to the Certificate of Analysis (CoA).

  • Form

    Lyophilized

  • Formulation

    Lyophilized from a 0.22 μm-filtered solution in PBS, with trehalose as protectant.

    Please contact us for customized product forms or formulations.

  • Reconstitution

    Please refer to the Certificate of Analysis (CoA) for specific instructions.

  • Shipping

    Lyophilized product is shipped at ambient temperature.

  • Storage

    For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • Notices

    Product Specific Notices: For research use only.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-ELISA

     IgG Fc ELISA

    Immobilized Monoclonal Anti-SARS-CoV-2 Spike RBD Antibody, Human IgG4 (337L) (Cat. No. SPD-M402a) at 2μg/mL (100μL/well) can bind Monoclonal Anti-Human IgG Fc Antibody, Mouse IgG1 (6F11C8) (Cat. No. IGG-S307) with a linear range of 0.05-3.13 ng/mL (QC tested).

    Protocol
  •  IgG Fc ELISA

    Immobilized human IgG1, IgG2, IgG3 and IgG4 Fc bind monoclona anti-human IgG Fc antibody, mouse IgG1 (6F11C8). The antibody does not bind human IgA1 Fc or His-tag (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

FAQ

  • product

    Can lyophilized proteins remain stable during room-temperature shipping or temporary room-temperature exposure?

    In general, lyophilized proteins remain stable during room-temperature shipping or temporary exposure to room-temperature conditions.


    Many ACROBiosystems recombinant proteins are supplied in lyophilized (freeze-dried) form. The lyophilization process effectively removes moisture from the product, helping reduce degradation-related reactions and improve protein stability during transportation and storage.


    To evaluate the stability of lyophilized proteins under normal temperature conditions, ACROBiosystems conducted a stability study on 11 representative lyophilized protein products at 37°C. The study demonstrated that these proteins maintained good quality stability after storage at 37°C for approximately 20 days. Based on these validation results, temporary room-temperature exposure during shipping or handling is generally not expected to have a significant impact on product quality or downstream application performance.


    To ensure optimal long-term stability, products should be stored according to the storage conditions specified in the product Certificate of Analysis (COA) upon receipt.


    Supporting Document


Background

Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport).

Recent Advances

 
Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • FAQ
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland